http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104610017-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D317-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C33-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C29-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F1-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C33-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-047 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C29-60 |
| filingDate | 2015-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104610017-B |
| titleOfInvention | One class halogenophenyl propanediol derivative, Preparation Method And The Use |
| abstract | The present invention relates to the pharmaceutical field relevant to diabetes.Specifically, the present invention relates to II type sodium dependent glucose transhipment (SGLT2) inhibitor of a class halogenophenyl propylene glycol structure, its preparation method and the application in preparation treatment diabetes medicament.n wherein, Rn 1 be selected from halogenic substituent; Rn 2 be selected from Cn 1 -Cn 5 alkyl. |
| priorityDate | 2015-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 61.